Email from Childrens Health Defense The Latest Defender News   Monday, July 27, 2026     3 Service Members Join Children’s Health Defense Lawsuit Against Air Force ⇱ SHARE ‘I Am the Most Famous’: Fauci Basked in Media Spotlight, Newly Released Diaries Show ⇱ SHARE Clinical Trial Results Were Clear: Pfizer’s COVID Vaccine Delivered More Risk Than Benefit ⇱ SHARE ‘Saving Babies’: Patricia Neuenschwander, ‘Fierce Advocate’ for Children’s Health, Dies at 59 ⇱ SHARE Public Health Needs MAHA + More ⇱ SHARE Ladera Ranch Erupts as Cancer Bosses Release New Figures on Extremely Rare Cluster Striking Kids + More ⇱ SHARE In case you missed it ... July 24, 2026 Pharma Looks to Cash in on Psychedelics as Patients Seek Alternatives to Psychotropic Drugs for Depression Eli Lilly’s multibillion-dollar acquisition of a company that makes experimental psychedelic therapies marks the largest investment yet by a drugmaker in psychedelic medicine as a treatment for depression. But pharma’s entry into the market raises questions about patents, profits and the future of psychedelic therapy. Add The Defender as a preferred source.     Now you can bookmark your favorite Defender articles to read them later. Not a CHD Insider yet? Join today with a small monthly donation to make a big impact.     Support news that prioritizes your children's well-being DONATE Children's Health Defense® is a 501(c)(3) non-profit organization. Our mission is ending childhood health epidemics by eliminating toxic exposure. We will restore and protect the health of children by eliminating environmental exposures, holding responsible parties accountable, and establishing safeguards to prevent future harm of children's health. Protecting Children. Exposing Harms. Seeking Justice. Children's Health Defense Childrens Health Defense | 852 Franklin Ave Suite 511 | Franklin Lakes, NJ 07417 US Unsubscribe | Update Profile | Our Privacy Policy | Constant Contact Data Notice